Valiglurax

Valiglurax (VU0652957) is an experimental drug that is a positive allosteric modulator for the glutamate receptor mGluR4. It was developed as a potential medication for the treatment of Parkinson's disease.^[1][2]

Valiglurax

Identifiers
IUPAC name N-(2H-pyrazolo[3,4-b]pyridin-3-yl)-1-(trifluoromethyl)isoquinolin-6-amine
CAS Number	1976050-09-5
PubChem CID	134191471
IUPHAR/BPS	10135
ChemSpider	88296853
ChEMBL	ChEMBL4797139
Chemical and physical data
Formula	C16H10F3N5
Molar mass	329.286 g·mol−1
3D model (JSmol)	Interactive image
SMILES C1=CC2=C(NN=C2N=C1)NC3=CC4=C(C=C3)C(=NC=C4)C(F)(F)F
InChI InChI=1S/C16H10F3N5/c17-16(18,19)13-11-4-3-10(8-9(11)5-7-20-13)22-15-12-2-1-6-21-14(12)23-24-15/h1-8H,(H2,21,22,23,24) Key:RUEXKBWCUUFJMY-UHFFFAOYSA-N